Furthermore, some combinations of genetic alterations showed low/no tumour penetrance in our GEMMs, for example, Trp53 modifications in combination with MYC overexpression, while these showed high penetrance in HCC in previous models using hydrodynamic tail vein injections12. Here, MYC is linked to neoplasm.